Intranasal creatine prodrug shows early brain activity in phase 1 trial
A phase 1 trial found that intranasal creatine prodrug CBT101 was tolerated and produced exploratory EEG changes consistent with central ...
A phase 1 trial found that intranasal creatine prodrug CBT101 was tolerated and produced exploratory EEG changes consistent with central ...
In recent years, the pursuit of innovative treatments for neuropsychiatric disorders has accelerated, driven by the urgent need to overcome ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine